An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten)SOUTH SAN FRANCISCO, ...

Heart failure disproportionately affects the black community, with research showing significantly higher rates compared to other populations. While various factors contribute to this disparity, ...

Add Yahoo as a preferred source to see more of our stories on Google. TUPELO — The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...

A recent Eli Lilly study found patients on Mounjaro were 38% less likely to be hospitalized and showed improved heart failure symptoms. The phase 3 clinical trial evaluating use of tirzepatide — the ...

Heart disease continues to rank as the leading cause of death in the Black community, claiming thousands of lives annually. While lifestyle modifications remain foundational to heart health, modern ...